Your search returned 6 results.

Results
	1.	Health-related quality-of-life assessment in gastrointestinal cancer: are results relevant for clinical practice? [electronic resource] by Conroy, Thierry Uwer, Lionel Deblock, Mathilde Producer: 20071012 In: Current opinion in oncology vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	[Primary mediastinal germs cells tumors: a twenty years experience in a comprehensive cancer center]. [electronic resource] by Joly, Charlotte Deblock, Mathilde Desandes, Emmanuel Geoffrois, Lionnel Producer: 20150330 In: Bulletin du cancer vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Prospective comparison of whole-body MRI with diffusion-weighted and conventional imaging for the follow-up of neuroendocrine tumors. [electronic resource] by Minon, Maximilien Soriano, Clothilde Morland, David Walter, Thomas Lepage, Côme Tabarin, Antoine Deblock, Mathilde Rousset, Pascal Barbe, Coralie Hoeffel, Christine Cadiot, Guillaume Producer: 20210621 In: Endocrine vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status. [electronic resource] by Gonçalves, Anthony Deblock, Mathilde Esterni, Benjamin Tarpin, Carole Bertucci, François Gilabert, Marine Charafe-Jauffret, Emmanuelle Jacquemier, Jocelyne Houvenaeghel, Gilles Extra, Jean-Marc Viens, Patrice Producer: 20091229 In: Anti-cancer drugs vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first-line therapy for triple-negative, metastatic, or locally advanced breast cancer: Results from the GINECO A-TaXel phase 2 study. [electronic resource] by Ferrero, Jean-Marc Hardy-Bessard, Anne-Claire Capitain, Olivier Lortholary, Alain Salles, Bruno Follana, Philippe Herve, Robert Deblock, Mathilde Dauba, Jérôme Atlassi, Mustapha Largillier, Rémy Producer: 20170525 In: Cancer vol. 122 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study. [electronic resource] by Bertucci, François Fekih, Mahmoud Autret, Aurélie Petit, Thierry Dalenc, Florence Levy, Christelle Romieu, Gilles Bonneterre, Jacques Ferrero, Jean-Marc Kerbrat, Pierre Soulie, Patrick Mouret-Reynier, Marie-Ange Bachelot, Thomas Lerebours, Florence Eymard, Jean-Christophe Deblock, Mathilde Lortholary, Alain Hardy-Bessard, Anne-Claire Barthelemy, Philippe Bonnefoi, Hervé Charafe-Jauffret, Emmanuelle Bidard, François-Clément Viens, Patrice Lemonnier, Jérôme Pierga, Jean-Yves Producer: 20170613 In: The Lancet. Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)